D-1820-2019 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1820-2019 was initiated by American Health Packaging on Mar 1, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples. The recall status is terminated (terminated Sep 30, 2020). Affected quantity: 13,229 cartons.

Recall details

Product Type
Drugs
Report Date
Aug 21, 2019
Initiation Date
Mar 1, 2019
Termination Date
Sep 30, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,229 cartons

Product description

Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg, 20 capsules per carton (5 blister cards x 4 unit doses), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-305-32; NDC Blister Pack: 60687-305-33

Reason for recall

Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.

Distribution pattern

Nationwide USA

Code information

Lot, expiry: Lot 174262, exp. 03/31/2019; Lot 176469, exp. 06/30/2019; Lot 177897, exp. 08/31/2019; Lots 178318 and 178436, exp. 09/30/2019; Lot 179547 and 179656, exp. 11/30/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1820-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1820-2019. Report a data issue: hello@regdatalab.com.